PE-Labeled Monoclonal Anti-Human CD223 / LAG-3 Antibody, Mouse IgG1 (AS659) (0.03% Proclin)

ユーザーレビュー
製品番号/仕様
価格
数量
FABm061-01-50tests
$240.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Source

    Monoclonal Anti-Human CD223 / LAG-3 Antibody, Mouse IgG1 (AS659) is a mouse monoclonal antibody, which provides higher batch consistency and long term security of supply.

  • Clone

    AS659

  • Isotype

    Mouse IgG1, Kappa

  • Host Species

    Mouse

  • Reactivity

    Human

  • Immunogen

    Purified Human CD223 / LAG-3 epsilon Protein

  • Conjugate

    PE

    Excitation Wavelength: 488 nm / 561 nm

    Emission Wavelength: 575 nm

  • Specificity

    This product is a specific antibody specifically reacts with CD223 / LAG-3 epsilon protein.

  • Application

    Flow Cytometry (Evaluation of the expression of CD223 / LAG-3 on Human cells).

  • Recommended Dilution

    1:20

  • Isotype Control

    The isotype control is sold separately; please refer to Cat. No. DNP-PM1 for product information.

  • Form

    Liquid

  • Formulation

    Supplied as 0.2 μm-filtered solution in PBS (pH 7.4) containing 0.03% ProClin 300 and 0.2% BSA, with trehalose as protectant.

    Please contact us for customized product forms or formulations.

  • Shipping

    Liquid product is shipped at blue ice.

  • Storage

    Please protect from light and avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. Store at 2-8 °C for 12 months.
  • Notices

    Product Specific Notices: For research use only.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • Bioactivity-FACS

     CD223 FACS

    Flow cytometric analysis of Human PD-1/LAG-3 (Luc) Jurkat Reporter cell staining with PE-Labeled Monoclonal Anti-Human LAG-3 Antibody, Mouse IgG1 (AS659) (Cat. No. FABm061-01) at 1:20 dilution (5 μL of the antibody stock solution corresponds to labeling of 1e6 cells in a final volume of 100 µL), compared with isotype control antibody. PE signal was used to evaluate the binding activity (QC tested).

    Protocol

ユーザーレビュー
コメントを投稿

バックグランド

This PE-conjugated anti-human CD223 (LAG-3) antibody specifically recognizes CD223 (Lymphocyte Activation Gene 3/Protein FDC), a high-performance tool for immunoregulatory research. CD223 (LAG-3) is a ~70 kDa Ig superfamily transmembrane glycoprotein, homologous to CD4, critical for T-cell signaling. Expressed on activated T cells, NK cells and Tregs (higher on CD8⁺ than CD4⁺ T cells), transient in acute activation but sustained under tolerance. As an activation-induced molecule, CD223 binds MHC class II with higher affinity than CD4 (competitive inhibition), associates with TCR-CD3 to downregulate signaling and T-cell expansion (negative T-cell regulation), and promotes dendritic cell activation. CD223 deficiency inhibits tumor growth; synergizes with PD-1 to reverse T-cell exhaustion, enhance tumor rejection and control viral loads. This antibody facilitates CD223 detection, immune mechanism study and tumor immunotherapy research.

最新の進展

 
お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8